Results 231 to 240 of about 124,603 (293)

Susceptibility Weighted Imaging in Migraines with and Without Aura: A Case-Control Study. [PDF]

Neurol Int
Scutelnic A, Klail T, Moor D, Slavova N, Petroulia V, Jung S, Branca M, Fischer U, Riederer F, Wiest R, Schankin CJ.   +10 more
europepmc   +1 more source

A retrospective cohort study to evaluate the effectiveness and safety profile of occipital nerve blocks in the treatment of migraine during pregnancy

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Nearly 12% of Americans experience migraine, with 75% of that group represented by women aged 15–55 years, notably including peak childbearing years. This presents a therapeutic dilemma for pregnant patients, given that most medications for migraine range from unknown teratogenicity in human pregnancies, at best, to known
Liza Smirnoff, Leon Moskatel, Blake Shaw, Zihuai He, Addie Peretz   +4 more
wiley   +1 more source

Migraine management in children - Review of strategies and Recommendations

, 1970
Narayan Chandra Kundu, Q Ahmad
openalex   +2 more sources

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

Pupillometry changes following ocular administration of brimonidine in patients experiencing acute migraine attack. [PDF]

Medicine (Baltimore)
Karakaya C, Kilic S, Yildirim I.
europepmc   +1 more source

[Migraine].

Arquivos de neuro-psiquiatria, 1968
openaire   +3 more sources

Reduction of opioid and barbiturate use following initiation of rimegepant for migraine in the United States

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The primary objective of this study was to evaluate opioid and barbiturate utilization before and after the first prescription of the calcitonin gene–related peptide receptor antagonist rimegepant in individuals with migraine. Background Although not recommended in migraine treatment guidelines, opioids and barbiturates are often ...
Noah Rosen, Aaron Jenkins, Karin Hygge Blakeman, Feng Dai, Lucy Abraham, Chelsea Leroue, Josh Brown   +6 more
wiley   +1 more source

From Headache to Heart Health: Investigating the Migraine-Cardiovascular Disease Connection. [PDF]

Neurol Ther
Tana C, Onan D, Messina R, Waliszewska-Prosół M, Garcia-Azorin D, Leal-Vega L, Coco-Martin MB, Ornello R, Raffaelli B, Souza MNP, Wells-Gatnik W, Martelletti P.   +11 more
europepmc   +1 more source

Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to assess the therapeutic efficacy of galcanezumab in preclinical models of migraine and cluster headache and to determine potential shared trigeminovascular mechanisms of action. Galcanezumab is a humanized monoclonal antibody that binds to the neuropeptide calcitonin gene‐related peptide ...
Marta Vila‐Pueyo, Peter J. Goadsby, Kirk W. Johnson, Philip R. Holland   +3 more
wiley   +1 more source

Dissecting Causal Relationships Between Gut Microbiota, Immunocyte Phenotype, and Migraine: A Mendelian Randomization Study. [PDF]

Brain Behav
Lai Y, Liu Y, Chen J, Cao Y, Zhang X, Li L, Zhou P, Sun P, Zhou J.   +8 more
europepmc   +1 more source